- Samsung Biologics’ product carbon footprint system has been validated by DNV, confirming alignment with ISO 14067 and PAS 2050 standards.
- The validated framework is intended to support transparent, comparable product-level carbon footprint data across biopharmaceutical manufacturing.
Samsung Biologics said its product carbon footprint system has been validated by Det Norske Veritas, an independent third-party assurance provider. The validation confirms that the company’s PCF calculation methodology aligns with globally recognized standards, including ISO 14067 and PAS 2050.
According to the company, DNV assessed the PCF system across data input, conversion, and output processes. The review confirmed that the assumptions, methods, and overall approach used in carbon accounting across biopharmaceutical manufacturing follow accepted global practices.
Samsung Biologics said the validated PCF framework is designed to support clearer communication and greater comparability of product-level carbon footprint data across the biopharmaceutical value chain. The system is intended to address evolving client expectations and sustainability requirements within CDMO and contract manufacturing operations.
“Achieving independent validation of our PCF system reflects the rigor and transparency of the carbon data we provide to clients.”
John Rim, President and CEO of Samsung Biologics
The company added that its broader sustainability efforts were also reflected in its recent assessment by EcoVadis, where Samsung Biologics received a Platinum rating, placing it among the top one percent of companies evaluated globally for sustainability management.
